ArticleInvestigational new drugs2013

First report of the safety, tolerability, and pharmacokinetics of the Src kinase inhibitor saracatinib (AZD0530) in Japanese patients with advanced solid tumours.

Yasuhito Fujisaka et al.PubMed ↗Publisher ↗

No numbers read from the abstract.